CRIS Current Research Information System

FAVONI, VALENTINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.829
EU - Europa 1.058
AS - Asia 679
AF - Africa 68
SA - Sud America 4
OC - Oceania 2
Totale 3.640
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.822
SG - Singapore 260
GB - Regno Unito 241
IT - Italia 219
CN - Cina 199
DE - Germania 174
SE - Svezia 154
IN - India 74
RU - Federazione Russa 62
VN - Vietnam 55
IE - Irlanda 52
JO - Giordania 39
FR - Francia 33
BG - Bulgaria 27
NG - Nigeria 25
ZA - Sudafrica 22
FI - Finlandia 19
UA - Ucraina 18
PK - Pakistan 16
AT - Austria 14
EE - Estonia 13
TG - Togo 10
CI - Costa d'Avorio 9
NL - Olanda 9
ID - Indonesia 8
BE - Belgio 7
CA - Canada 7
TH - Thailandia 6
HK - Hong Kong 4
JP - Giappone 4
LT - Lituania 4
CH - Svizzera 3
IL - Israele 3
UZ - Uzbekistan 3
BR - Brasile 2
CZ - Repubblica Ceca 2
GR - Grecia 2
IR - Iran 2
KR - Corea 2
LB - Libano 2
QA - Qatar 2
RO - Romania 2
SC - Seychelles 2
AR - Argentina 1
AU - Australia 1
BY - Bielorussia 1
CL - Cile 1
HR - Croazia 1
NZ - Nuova Zelanda 1
PL - Polonia 1
Totale 3.640
Salva come PNG Salva come JPEG
Città #
Southend 227
Singapore 220
Fairfield 213
Santa Clara 160
Woodbridge 122
Ashburn 116
Chandler 112
Houston 103
Seattle 93
Ann Arbor 91
Princeton 80
Wilmington 80
Cambridge 78
Boardman 56
Dublin 52
Amman 39
Turin 39
Bologna 34
Sofia 27
Abeokuta 25
Redmond 25
Westminster 23
Dong Ket 22
San Diego 21
Berlin 20
Chengdu 18
Helsinki 15
Nanjing 15
Des Moines 14
Monzuno 14
Milan 12
Lomé 10
Saint Petersburg 10
Abidjan 9
Hebei 9
Nanchang 9
Padova 9
Shanghai 9
Shenyang 9
Beijing 8
Falkenstein 8
Guangzhou 8
Jakarta 8
New York 8
Brussels 7
Dearborn 7
Jacksonville 7
Jiaxing 7
Jinan 7
Muzaffargarh 7
Nuremberg 7
Redwood City 7
Vienna 7
Hyderabad 6
Olalla 6
Phoenix 6
Bangkok 5
Changsha 5
Imola 5
Los Angeles 5
Parma 5
Shenzhen 5
Tianjin 5
Yubileyny 5
Chicago 4
Costa Mesa 4
Council Bluffs 4
Florence 4
Gujranwala 4
Hangzhou 4
Hong Kong 4
Lappeenranta 4
Pianoro 4
Wuhan 4
Amsterdam 3
Bühl 3
Frankfurt am Main 3
Mülheim 3
Ningbo 3
Norwalk 3
San Mateo 3
Seriate 3
Silvi 3
Taiyuan 3
Washington 3
Zhengzhou 3
Atlanta 2
Bari 2
Bolzano 2
Bremen 2
Brno 2
Chongqing 2
Doha 2
Edmonton 2
Falls Church 2
Frankfurt Am Main 2
Groningen 2
Haikou 2
Hanover 2
Harbin 2
Totale 2.505
Salva come PNG Salva come JPEG
Nome #
Idiopathic intracranial hypertension without papilledema (IIHWOP) in chronic refractory headache 142
Cerebrospinal fluid hypocretin-1 levels during the active period of cluster headache. 136
Treatment of withdrawal headache in patients with medication overuse headache: a pilot study 135
Migraine and sleep disorders. 124
Interobserver reliability of ICSD-3 diagnostic criteria for disorders of arousal in adults 124
A real-world study on unmet medical needs in triptan-treated migraine: Prevalence, preventive therapies and triptan use modification from a large Italian population along two years 123
Greater Occipital Nerve Infiltration During Pregnancy in Cluster Headache: A Case Report 120
Vessel-wall MRI in primary headaches: The role of neurogenic inflammation 116
Superficial siderosis associated with peripheral autonomic failure and tetraventricular hydrocephalus: a case report 106
The incidental finding of elevated anti GQ1B antibodies in a patient with selective small fiber neuropathy 105
Clinical and radiological prognostic factors in spontaneous intracranial hypotension: a case series 105
Transverse Sinus Stenosis in Refractory Chronic Headache Patients: An Observational Study 102
Migraine and cardiovascular diseases. 100
CGRP and migraine from a cardiovascular point of view: What do we expect from blocking CGRP? 99
SUNCT/SUNA and neurovascular compression: New cases and critical literature review. 97
Rotigotine Objectively Improves Sleep in Parkinson's Disease: An Open-Label Pilot Study with Actigraphic Recording 97
SPARTACUS: underdiagnosis of chronic daily headache in primary care. 97
Quality indicators in headache care: an implementation study in six Italian specialist-care centres 93
Recurrent Reversible Cognitive Impairment in a Cluster Headache Patient: A Case Report 92
Rare primary headaches in Italian tertiary Headache Centres: Three year nationwide retrospective data from the RegistRare Network 90
Nociception and autonomic nervous system. 89
Energy Metabolism Impairment in Migraine 88
State and trait anger and its expression in cluster headache compared with migraine: a cross-sectional study 86
Real-life assessment of erenumab in refractory chronic migraine with medication overuse headache 83
null 80
Erenumab efficacy in highly resistant chronic migraine: a real-life study 78
Detoxification vs non-detoxification before starting an anti-CGRP monoclonal antibody in medication overuse headache 78
Erenumab in 159 high frequency and chronic migraine patients: real-life results from the Bologna Headache Center 72
Great occipital nerve long-acting steroid injections in cluster headache therapy: an observational prospective study 71
Nummular headache: a gender-oriented perspective on a case series from the RegistRare Network 70
Galcanezumab for the prevention of high frequency episodic and chronic migraine in real life in Italy: a multicenter prospective cohort study (the GARLIT study) 69
Vessel-wall MRI in thunderclap headache: A useful tool to answer the riddle? 64
Effectiveness, safety, and tolerability of galcanezumab in a real-life setting in patients with migraine in Italy (the GARLIT study) 59
Locking down the CGRP pathway during the COVID-19 pandemic lockdown: the PandeMig study 58
Insights into real-world treatment of cluster headache through a large Italian database: prevalence, prescription patterns, and costs 55
P063. Colloid cysts of the third ventricle: a case report 54
Migraine chronification as an allostatic disorder: a proof-of-concept study 47
Chronic Migraine and Medication Overuse Headache Worsening After OnabotulinumtoxinA Withdrawn Due to the Severe Acute Respiratory Syndrome-Coronavirus-2 Pandemic 46
Long-term (48 weeks) effectiveness, safety, and tolerability of erenumab in the prevention of high-frequency episodic and chronic migraine in a real world: Results of the EARLY 2 study 44
Is physiotherapy in migraines known to sufferers? A cross-sectional study 29
Blood pressure monitoring in elderly migraineurs starting an anti-CGRP monoclonal antibody: a real-world prospective study 29
Rapid response to galcanezumab and predictive factors in chronic migraine patients: A 3-month observational, longitudinal, cohort, multicenter, Italian real-life study 25
Self-administered subcutaneous diclofenac sodium in acute migraine attack: A randomized, double-blind, placebo-controlled dose-finding pilot study 25
Greater occipital nerve blockade in cluster headache: effectiveness and safety of a combined injection protocol 24
Burden and attitude to resistant and refractory migraine: a survey from the European Headache Federation with the endorsement of the European Migraine & Headache Alliance 17
An unusual case of anti-basal ganglia encephalitis showing polyradiculoneuritis features 16
Central and Peripheral Nervous Disorders 16
Ultra-late response (> 24 weeks) to anti-CGRP monoclonal antibodies in migraine: a multicenter, prospective, observational study 13
Maintenance of response and predictive factors of 1-year GalcanezumAb treatment in real-life migraine patients in Italy: The multicenter prospective cohort GARLIT study 12
Chronic migraine evolution after 3 months from erenumab suspension: real-world-evidence-life data 11
The ultimate guide to the anti-CGRP monoclonal antibodies galaxy 9
Conversion from chronic to episodic migraine in patients treated with galcanezumab in real life in Italy: the 12-month observational, longitudinal, cohort multicenter GARLIT experience 9
Discontinuing monoclonal antibodies targeting CGRP pathway after one-year treatment: an observational longitudinal cohort study 8
Moving closer to the ideal migraine acute treatment 8
Gender Differences in 3-Month Outcomes of Erenumab Treatment-Study on Efficacy and Safety of Treatment With Erenumab in Men 8
Comparing the relative and absolute effect of erenumab: is a 50% response enough? Results from the ESTEEMen study 6
Totale 3.759
Salva come PNG Salva come JPEG
Categoria #
all - tutte 12.152
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.152
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020136 0 0 0 0 0 0 0 0 0 46 47 43
2020/2021399 91 27 4 17 18 11 14 29 60 25 18 85
2021/2022635 37 16 41 31 63 20 13 85 21 75 142 91
2022/2023681 64 69 23 81 67 43 38 38 144 29 65 20
2023/2024290 10 42 23 47 11 51 24 19 8 29 9 17
2024/2025852 50 239 90 71 220 65 60 43 11 3 0 0
Totale 3.759